MedWatch

WSA is not yet committed to OTC – but has FDA-approved device ready

The hearing aid group has had a self-fitting hearing aid approved by the FDA, essentially positioning the firm for when the upcoming over-the-counter sales channel open – but CEO Eric Bernard won’t say if this is the plan.

Eric Bernard, CEO of WS Audiology | Photo: WS Audiology / PR

The world’s third-biggest hearing aid group, WS Audiology, has silently submitted and received approval for a self-fitting hearing aid with the US Food and Drug Administration (FDA).

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs